Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 1.4%.

  • Phathom Pharmaceuticals' Return on Capital Employed fell 4000.0% to 1.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.4%, marking a year-over-year decrease of 4000.0%. This contributed to the annual value of 0.89% for FY2024, which is 2300.0% down from last year.
  • Phathom Pharmaceuticals' Return on Capital Employed amounted to 1.4% in Q3 2025, which was down 4000.0% from 1.49% recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Return on Capital Employed registered a high of 0.58% during Q4 2023, and its lowest value of 1.49% during Q2 2025.
  • Its 4-year average for Return on Capital Employed is 0.98%, with a median of 0.97% in 2024.
  • As far as peak fluctuations go, Phathom Pharmaceuticals' Return on Capital Employed soared by 5700bps in 2024, and later crashed by -6200bps in 2025.
  • Quarter analysis of 4 years shows Phathom Pharmaceuticals' Return on Capital Employed stood at 1.1% in 2022, then surged by 47bps to 0.58% in 2023, then crashed by -60bps to 0.93% in 2024, then crashed by -50bps to 1.4% in 2025.
  • Its Return on Capital Employed stands at 1.4% for Q3 2025, versus 1.49% for Q2 2025 and 1.09% for Q1 2025.